Institute for Human Genetics and Genome Medicine, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Institute for Stem Cell Biology, Medical Faculty, RWTH Aachen University, Aachen, Germany.
Mol Genet Genomic Med. 2023 Dec;11(12):e2264. doi: 10.1002/mgg3.2264. Epub 2023 Jul 31.
Beckwith-Wiedemann syndrome and Silver-Russel syndrome are two imprinting disorders caused by opposite molecular alterations in 11p15.5. With the current diagnostic tests, their molecular diagnosis is challenging due to molecular heterogeneity and mosaic occurrence of the most frequent alterations. As the determination of precise (epi)genotype of patients is relevant as the basis for a personalized treatment, different approaches are needed to increase the sensitivity of diagnostic testing of imprinting disorders.
We established methylation-specific droplet digital PCR approaches (MS-ddPCR) for the two imprinting centers in 11p15.5, and analyzed patients with paternal uniparental disomy of chromosome 11p15.5 (upd(11)pat) and other imprinting defects in the region. The results were compared to those from MS-MLPA (multiplex ligation-dependent probe amplification) and MS-pyrosequencing.
MS-ddPCR confirmed the molecular alterations in all patients and the results matched well with MS-MLPA. The results of MS-pyrosequencing varied between different runs, whereas MS-ddPCR results were reproducible.
We show for the first time that MS-ddPCR is a reliable and easy applicable method for determination of MS-associated changes in imprinting disorders. It is therefore an additional tool for multimethod diagnostics of imprinting disorders suitable to improve the diagnostic yield.
贝克威思-威德曼综合征和西尔弗-拉塞尔综合征是两种印记疾病,由 11p15.5 上相反的分子改变引起。目前的诊断测试由于最常见的改变存在分子异质性和镶嵌发生,因此其分子诊断具有挑战性。由于确定患者的确切(表观)基因型与个性化治疗的基础相关,因此需要不同的方法来提高印记疾病诊断测试的敏感性。
我们建立了用于 11p15.5 中两个印记中心的甲基化特异性液滴数字 PCR 方法(MS-ddPCR),并分析了具有 11p15.5 染色体单亲二体性(upd(11)pat)和该区域其他印记缺陷的患者。将结果与 MS-MLPA(多重连接依赖性探针扩增)和 MS-焦磷酸测序进行比较。
MS-ddPCR 证实了所有患者的分子改变,结果与 MS-MLPA 吻合良好。MS-焦磷酸测序的结果在不同运行之间存在差异,而 MS-ddPCR 的结果具有可重复性。
我们首次表明,MS-ddPCR 是一种可靠且易于应用的方法,可用于确定印记疾病中与 MS 相关的改变。因此,它是一种适合提高诊断产量的多方法印记疾病诊断的附加工具。